Chemoradiation of hepatic malignancies: Prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 5, 2014, Pages 1025-1031

  Hickey, Ryan ^a   Mulcahy, Mary F ^b   Lewandowski, Robert J ^a   Gates, Vanessa L ^a   Vouche, Michael ^a   Habib, Ali ^a   Kircher, Sheetal ^b   Newman, Steven ^b   Nimeiri, Halla ^b   Benson, Al B ^b   Salem, Riad ^a,b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPEUTIC AGENTS; CHOLANGIOCARCINOMA; DOSE LIMITING TOXICITY; INITIAL TREATMENT; MAXIMUM TOLERATED DOSE; METASTATIC DISEASE; METHODS AND MATERIALS; RADIOEMBOLIZATION;

CHEMOTHERAPY; RADIATION EFFECTS; TOXICITY;

PATIENT TREATMENT;

CAPECITABINE; FLUOROURACIL; MACROSALB TC 99M; YTTRIUM 90;

ABDOMINAL PAIN; ANOREXIA; ARTICLE; ASCITES; BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CHOLECYSTITIS; CLINICAL PROTOCOL; DIARRHEA; DIGESTIVE SYSTEM ULCER; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG INFUSION; FATIGUE; HAND FOOT SYNDROME; HUMAN; HYPERBILIRUBINEMIA; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER METASTASIS; MAXIMUM TOLERATED DOSE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; PHASE 1 CLINICAL TRIAL; PLEURA EFFUSION; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL; TREATMENT PLANNING; VOMITING; WEIGHT REDUCTION; XEROSIS;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; CHOLANGIOCARCINOMA; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOMETRY; TIME FACTORS; TREATMENT OUTCOME; YTTRIUM;

EID: 84897890056     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.12.040     Document Type: Article

References (29)

1. C.G. Moertel, S. Frytak, and R.G. Hahn et al. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group Cancer 48 1981 1705 1710
2. M. al-Sarraf, K. Martz, and A. Herskovic et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study J Clin Oncol 15 1997 277 284
3. Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group N Engl J Med 312 1985 1465 1472
4. B. Emami, J. Lyman, and A. Brown et al. Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 1991 109 122
5. A.S. Kennedy, C. Nutting, and D. Coldwell et al. Pathologic response and microdosimetry of (90)Y microspheres in man: Review of four explanted whole livers Int J Radiat Oncol Biol Phys 60 2004 1552 1563
6. R. Salem, and K.G. Thurston Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations J Vasc Interv Radiol 17 2006 1251 1278
7. R. Hickey, M. Vouche, D.Y. Sze, E. Hohlastos, J. Collins, and T. Schirmang et al. Cancer Concepts and Principles: Primer for the Interventional Oncologist-Part II J Vasc Interv Radiol 24 2013 1167 1188
8. M. Miwa, M. Ura, and M. Nishida et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue Eur J Cancer 34 1998 1274 1281
9. N. Sawada, T. Ishikawa, and F. Sekiguchi et al. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts Clin Cancer Res 5 1999 2948 2953
10. C. Le Tourneau, J.J. Lee, and L.L. Siu Dose escalation methods in phase I cancer clinical trials J Natl Cancer Inst 101 2009 708 720
11. B. Gray, G. Van Hazel, and M. Hope et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer Ann Oncol 12 2001 1711 1720
12. G. Van Hazel, A. Blackwell, and J. Anderson et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer J Surg Oncol 88 2004 78 85
13. R.A. Sharma, G.A. Van Hazel, and B. Morgan et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy J Clin Oncol 25 2007 1099 1106
14. G.A. van Hazel, N. Pavlakis, and D. Goldstein et al. Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy J Clin Oncol 27 2009 4089 4095
15. A. Hendlisz, M. Van den Eynde, and M. Peeters et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy J Clin Oncol 28 2010 3687 3694
16. S. Kosmider, T.H. Tan, and D. Yip et al. Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer J Vasc Interv Radiol 22 2011 780 786
17. T.S. Lawrence, J.M. Robertson, and M.S. Anscher et al. Hepatic toxicity resulting from cancer treatment Int J Radiat Oncol Biol Phys 31 1995 1237 1248
18. D. Habermehl, K.K. Herfarth, and J.L. Bermejo et al. Single-dose radiosurgical treatment for hepatic metastases: Therapeutic outcome of 138 treated lesions from a single institution Radiat Oncol 8 2013 175
19. A.C. Tree, V.S. Khoo, and R.A. Eeles et al. Stereotactic body radiotherapy for oligometastases Lancet Oncol 14 2013 e28 e37
20. J.C. Andrews, S.C. Walker, and R.J. Ackermann et al. Hepatic radioembolization with yttrium-90 containing glass microspheres: Preliminary results and clinical follow-up J Nucl Med 35 1994 1637 1644
21. P.M. Hoff, R. Ansari, and G. Batist et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study J Clin Oncol 19 2001 2282 2292
22. E. Van Cutsem, C. Twelves, and J. Cassidy et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study J Clin Oncol 19 2001 4097 4106
23. J.L. Blum, S.E. Jones, and A.U. Buzdar et al. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer J Clin Oncol 17 1999 485 493
24. T.F. Jakobs, S. Saleem, and B. Atassi et al. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres Dig Dis Sci 53 2008 2556 2563
25. V.L. Gates, K.G. Marshall, K. Salzig, M. Williams, R.J. Lewandowski, and R. Salem Outpatient single-session yttrium-90 glass microsphere radioembolization J Vasc Interv Radiol 25 2014 266 270
26. K. Sato, R.J. Lewandowski, and J.T. Bui et al. Treatment of Unresectable Primary and Metastatic Liver Cancer with Yttrium-90 Microspheres (TheraSphere(R)): Assessment of Hepatic Arterial Embolization Cardiovasc Intervent Radiol 22 2006 522 529
27. A. Kennedy, S. Nag, and R. Salem et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 2007 13 23
28. R. Murthy, H. Xiong, and R. Nunez et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results J Vasc Interv Radiol 16 2005 937 945
29. R. Salem, R.J. Lewandowski, and V.L. Gates et al. Research reporting standards for radioembolization of hepatic malignancies J Vasc Interv Radiol 22 2011 265 278